SIM
BLUE

Spark Investment Management’s bluebird bio BLUE Stock Holding History

Spark Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,732
Closed -$5.24M – 756
2015
Q3 		$5.24M Buy
4,732
+1,953
+70% +$3.56M 0.68% 19
2015
Q2 		$6.06M Buy
+2,779
New +$5.66M 0.85% 9
2013
Q4 		– Sell
-1,158
Closed -$406K – 651
2013
Q3 		$406K Buy
+1,158
New +$430K 0.09% 306

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Spark Investment Management's BLUE Position: Q4 2015 in Review

Spark Investment Management sold out of bluebird bio (BLUE) in Q4 2015, closing a stake of 4,732 shares — an estimated $5.24M sold.

Spark Investment Management first reported a position in BLUE in Q3 2013 and held it in 3 quarters. The position peaked at $6.06M in Q2 2015. 193 funds tracked by Wall St. Rank hold BLUE as of Q4 2015.

  • Spark Investment Management reported no remaining bluebird bio position as of Q4 2015 after selling out during the quarter.
  • Spark Investment Management sold 4,732 bluebird bio shares in Q4 2015, an estimated $5.24M.
  • Spark Investment Management first reported a position in bluebird bio in Q3 2013 and held it in 3 quarters.
  • Spark Investment Management's bluebird bio position peaked at $6.06M in Q2 2015.
  • 193 funds tracked by Wall St. Rank held bluebird bio as of Q4 2015.

Based on Spark Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.